i2E Managementi2E Managementi2E Managementi2E Management
  • About
  • Portfolio
  • Team
  • Funds
  • Investor Login

Tetherex Pharmaceuticals is developing novel products to treat thrombosis inflamatory disease and cancer.  Its lead clinical program is focused on an antibody names SelK2 initally under development for the treat of venous thromboembolism and Crohn’s desease.

Year Founded: 2014

Year Partnered: 2014

Category: BioTech/Pharma

Fund: Angel Fund II, Accelerate, Oklahoma Seed Capital Fund  

www.tetherex.com

  • Disclaimer & Disclosure

Oklahoma City Location

840 Research Parkway, Suite 250
OKC, OK 73104
PHONE 405/235-2305

Tulsa Location

618 E. Third Street, Suite 1
Tulsa, OK 74120
PHONE 918/582-5592

  • Disclaimer & Disclosure
Copyright 2021 i2E, Inc. | All Rights Reserved
  • About
  • Portfolio
  • Team
  • Funds
i2E Management